Postoperative Dexmedetomidine in Prevention of Postoperative Delirium
Status:
COMPLETED
Trial end date:
2024-04-28
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn how postoperative infusion of dexmedetomidine would influence postoperative delirium in elderly patients undergoing lung surgery. The main questions it aims to answer are :
1. Does postoperative dexmedetomidine reduce the incidence of delirium after lung surgery?
2. Does postoperative dexmedetomidine introduce other medical problems? Researchers will compare dexmedetomidine and sufentanil to see if dexmedetomidine works to reduce delirium.
Participants will undergo routine postoperative care:
1. Patient-controlled self anesthesia with sufentanil only or combination of sufentanil and dexmedetomidine
2. Postoperative visit twice a day for at least seven days
Phase:
NA
Details
Lead Sponsor:
Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.